Chemoenzymatic Synthesis of Synthes as Precursors for Enantiopure Clenbuterol and Other β2 Agonists

Autor: Wei Zhu, Sigvart Evjen, Mari Bergan Hansen, Fredrik Heen Blindheim, Elisabeth Egholm Jacobsen
Rok vydání: 2018
Předmět:
Zdroj: Catalysts, Vol 8, Iss 11, p 516 (2018)
Catalysts
Volume 8
Issue 11
ISSN: 2073-4344
DOI: 10.3390/catal8110516
Popis: Clenbuterol is a &beta
2-agonist used in the veterinary treatment of asthma in several countries. The drug is listed on the World Antidoping Agency&rsquo
s prohibited list due to its effect on increased protein synthesis in the body. However, racemic clenbuterol has recently been shown to reduce the risk of Parkinson&rsquo
s disease. In order to reveal which one (or both) of the enantiomers that cause this effect, pure enantiomers need to be separately studied. (R)-1-(4-Amino-3,5-dichlorophenyl)-2-bromoethan-1-ol has been synthesised in 93% enantiomeric excess (ee) by asymmetric reduction of the corresponding ketone catalysed by a ketoreductase and nicotinamide adenine dinucleotide phosphate (NADPH) as the cofactor in dimethyl sulfoxide (DMSO). (S)-N-(2,6-Dichloro-4-(1-hydroxyethyl)phenyl)acetamide has been synthesised in >
98% ee by the same system. Both synthons are potential precursors for clenbuterol enantiomers.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje